Precise, Proven and now Portable; The clinical standard for beat-to-beat ultrasound imaging of cardiac output just got better.

Over 1200 health professionals will descend on London’s ExCel for this year’s Anaesthesia and Critical Care (ACC) Conference, Nov 15th/16th 2022. The event comprises two days of packed educational sessions, with participants earning valuable CPD points, approved by the Royal College of Anaesthetists. 

Among the 75+ exhibitors will be UK haemodynamic monitoring specialist Deltex Medical. On stand H01 delegates will be able to preview the company’s brand new TrueVue™, which incorporates the system’s biggest ever raft of clinician-driven innovations. 

With Deltex’s proprietary oesophageal Doppler (ODM+) at its core, TrueVue’s enhancements mean it now better addresses clinician demands and can be applied in more clinical settings.

Deltex is keen to draw attention to upgrades to its already-remarkable technology. However, it’s changes to the systems usability and portability that are perhaps the most eye-catching. For the first time this makes it applicable in all hospital settings and transferable with the patient. Coupled with improvements in signal acquisition and maintenance, clinicians will be better able to deliver the proven benefits of Doppler monitoring to more patients. 

Deltex can now proudly claim that New TrueVue with ODM+ is the easiest to learn, simplest to use haemodynamic imaging technology ever! 

TrueVue’s user-focused improvements

Versatile and usable, key changes to TrueView mean:

  • Haemodynamic monitoring in all settings: Versatility is the keyword. Compact new system is now portable and battery-powered, making TrueView applicable in a much broader range of clinical situations. 
  • Hugely improved signal acquisition: Completely redeveloped signal processing with enhanced noise reduction (Dopplink).
  • Hugely improved signal maintenance: New probe clip ensures probe remains in desired orientation 
  • Full control of your data: HD Touchscreen with completely redesigned, intuitive user interface.

Our experts are on hand on stand H01 to discuss how New TrueVue can deliver for you. 

New TrueVue: Another milestone on the mission to eliminate complications caused by haemodynamic instability.

Terminus Road | Chichester | PO19 8TX | United Kingdom

  • Enquiries: +44 1243 774837
  • Email: marketing@deltexmedical.com
  • Deltex App:


Registered in England & Wales Company No: 1691369